CREATIVE EDGE NUTRITION INC

CREATIVE EDGE NUTRITION INC

OOTC:FITX
0.00
USD
0.00
(0.00%)
0.00EPS
127.91MMarket Cap
2007 Y
2008 Y
2009 Y
TTM
Revenue per Share
0.03
0.03
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Book Value per Share
0.01
0.01
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
Basic Weighted Avg Shares
11
12
196
289
Sales/Revenue/Turnover
- -
- -
- -
- -
Operating Margin (%)
13.98
0.24
-93.5
-194.55
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
13.98
0.24
-82.65
-141.24
Working Capital
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
0.88
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'10
Mar'10
Jun'10
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
331
331
341
Market Capitalization
- -
28
128

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-122.41%
Free Cash Flow
- -
- -
-38.93%
Net Income, GAAP
- -
- -
-9,836.71%
Sales/Revenue/Turnover
- -
- -
-71.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -

Company Description

CEO
Tim Matula
Full Time Employees
5
Sector
Health technology
Industry
Pharmaceuticals: other
Address
29235 Stephenson Highway Madison Heights MI United States 48071
IPO Date
Aug 4, 2008
Business
Creative Edge Nutrition, Inc. (FITX) develops, manufactures, markets, and sells a portfolio of health-oriented nutraceuticals and dietary supplements focused on active lifestyles and fitness, offering products in categories including weight loss and metabolic enhancement; recovery and well-being; muscle enhancement and stimulation; energy and fitness; and natural wellness lines. Its core branded products comprise MetaBolic Xtreme for weight loss; Hyper-Infusion, a pre-workout powder to boost endurance and strength; Alpha-Drive for post-cycle therapy; Amino Plex as an intra-workout recovery catalyst; Chia Plex for overall health and well-being; Hemp Plex; CentroPlex; Hemp Nutra Tea; and Nutra Coffee additives, available in formats such as tablets, capsules, powders, and science-based formulations targeting weight management, specific nutrition challenges, and performance enhancement. The company provides these offerings to consumer markets in the United States and internationally through direct-to-consumer channels, private labeling, and branded distribution, while also engaging in business acceleration, management, and proprietary marketing strategies for related industries. Founded in 2002 and headquartered at 29235 Stephenson Highway, Suite 206, Madison Heights, Michigan, the company formerly operated as Laufer Bridge Enterprises Inc. before changing its name in April 2012. In recent years, Creative Edge Nutrition has faced regulatory challenges, including Health Canada rejections of partner Cen Biotech's applications and local opposition to operations in Lakeshore, alongside negative publicity from shareholder concerns and media scrutiny over operational issues. Earlier acquisitions include Science Defined Nutrition in 2012 to bolster innovative product development and A-Z-Nutrition.com as its second direct-to-consumer retail supplement deal that year, though no major funding rounds, partnerships, or new launches have been reported in the last 1-2 years amid stagnant financials and a minimal market capitalization.